S&P 500 Healthcare Sector SPDR (XLV)

GE HealthCare has outperformed the healthcare sector over the past year, and analysts are moderately optimistic about the stock’s prospects.

Zimmer Biomet has underperformed the healthcare sector over the past year, yet analysts remain moderately bullish about the stock’s prospects.

CVS Health has significantly underperformed the healthcare sector over the past year, but analysts are moderately optimistic about the stock’s prospects.

Agilent Technologies has underperformed the healthcare sector lately, and analysts are moderately optimistic about the stock’s potential.

Cencora has outperformed other healthcare stocks over the past year and analysts remain bullish about the stock’s prospects.

The U.S. economy added 142,000 jobs in August 2024, more than a downwardly revised 89,000 in July but below forecasts of 160,000. Job gains occurred in construction, health care, government and social...

Despite Stryker’s outperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

September could further increase market volatility. Often termed as Wall Street’s worst month, September has been challenging for traders. According to Yahoo Finance, for the past 98 years, September...

Merck & Co. has underperformed the healthcare sector this year, but Wall Street analysts are bullish about the stock prospects.

IQVIA Holdings has underperformed the broader market this year, but Wall Street analysts are bullish about the stock’s prospects.